Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: A Study on the Efficacy and Safety of Golidocitinib Combined With Tislelizumab and Chemotherapy as First-line Treatment for Advanced NSCLC [Phase 1]
A Phase 1 clinical trial evaluating the safety and preliminary efficacy of combining Golidocitinib with Tislelizumab and chemotherapy as fir…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Interventional Ablation for Early-stage Lung Cancer
An update on a clinical trial evaluating interventional ablation for early-stage non-small cell lung cancer, currently active but not recrui…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Comparison Paravertebral and Serratus Anterior Plane Block in Video-assisted Thoracoscopic Surgery. [NA]
Clinical trial comparing paravertebral block versus serratus anterior plane block for anesthesia in video-assisted thoracoscopic surgery in …
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating papaverine in combination with chemoradiation for stage II-III non-small cell lung cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: AK129 Combination Therapy for Advanced Solid Tumors [Phase 1, Phase 2]
AK129 is being studied in Phase 1/2 trials for multiple advanced solid tumors, including non-small cell lung cancer and head and neck squamo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients [Phase 3]
Phase 3 trial comparing HD204 to Avastin in advanced non-squamous non-small cell lung cancer is active but not recruiting, evaluating effica…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies [Phase 1]
A Phase 1 clinical trial evaluating the safety and tolerability of AWT020 in patients with advanced malignancies is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Liquid BiOpsy, Lung and Colon Cancer in AndaluciA
A clinical trial update about a liquid biopsy program in Andalusia for non-small cell lung cancer and colorectal cancer, currently enrolling…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Stereotactic Body Radiotherapy Followed by Tislelizumab Plus Platinum-based Chemotherapy Versus Tislelizumab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer: A Phase Ⅲ, Randomized, Multicenter, Prospective Study [Phase 3]
Phase 3 randomized, multicenter trial in resectable stage II-III non-small cell lung cancer evaluating SBRT followed by tislelizumab plus pl…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors [Phase 1]
Phase 1 trial evaluating safety and biomarker signals for DK210, an EGFR-targeting therapy, across multiple EGFR-positive solid tumors; curr…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Radiation-induced Toxicity of the Heart [NA]
This clinical trial update describes a study on radiation-induced heart toxicity in cancers including non-small cell lung cancer and esophag…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Physical Activity During Chemo- and/or Immunotherapy for Lung Cancer
A clinical trial update describes a study of physical activity during chemotherapy and/or immunotherapy in non-small cell lung cancer, with …
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating nivolumab and ipilimumab in combination with immunogenic chemotherapy for patients with advanced non-s…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)
This clinical trial update indicates ongoing recruitment to evaluate the effectiveness and safety of Trastuzumab deruxtecan (T-DXd) in Chine…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity [Phase 2]
Phase 2 clinical trial update examining how intratumour heterogeneity influences antitumor response and resistance in non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC [Phase 1, Phase 2]
Status update on ONC-392 showing safety, pharmacokinetics, and preliminary efficacy in monotherapy and in combination with anti-PD-1 across …
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)
This clinical trial update discusses the role of gene molecular alterations as prognostic markers in patients with non-small cell lung cance…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing [Phase 2]
NeoTRACK is a Phase 2 trial evaluating immuno-oncology efficacy in non-small cell lung cancer; the study is currently active but not recruit…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC [Phase 2]
The PROPHET study is a Phase 2 clinical trial evaluating ctDNA-guided personalized induction immunochemotherapy for non-small cell lung canc…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer [Phase 3]
This is a Phase 3 trial evaluating osimertinib with or without chemotherapy versus chemotherapy alone as neoadjuvant therapy for patients wi…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
This clinical trial update describes a Shanghai Chest Hospital study analyzing the molecular landscape of non-small cell lung cancer patient…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer
This clinical trial analyzes resistance to immune checkpoint inhibitors in non-small cell lung cancer. It is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC. [Phase 2]
Phase 2 trial evaluating first-line Vebreltinib plus PLB1004 in patients with EGFR-mutant, MET-positive locally advanced or metastatic Non-S…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI [Phase 1, Phase 2]
This Clinical Trial Update describes a Phase 1/2 study of Vebreltinib plus PLB1004 in EGFR-mutated, advanced non-small cell lung cancer with…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Vebreltinib Plus PLB1004 Versus Platinum-based Doublet Chemotherapy in Patients With EGFRm, MET+, Locally Advanced or Metastatic NSCLC Following EGFR-TKI Failure [Phase 3]
Phase 3 trial evaluating Vebreltinib plus PLB1004 versus platinum-based doublet chemotherapy in EGFR-mutant, MET-positive non-small cell lun…